<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>15(1)</volume><submitter>Sharma A</submitter><pubmed_abstract>A series of 5-(substituted benzylidene) thiazolidine-2,4-dione and coumarin hybrids (I-1 to I-16) were designed and synthesized to explore key structural requirements for effective α-glucosidase inhibitors. Molecular docking studies were conducted to investigate their interactions with various targets, including DPP-4, α-glucosidase, α-amylase, and PPAR-γ. The docking scores and binding energies indicated that Compound I-1 emerged as the optimal scaffold for drug design, excluding α-amylase. Compound I-1 was synthesized based on the insights gained from molecular docking and simulations, which helped predict interactions and identify critical structural features. Pharmacokinetic properties were evaluated through drug-likeness and ADMET studies. Additionally, density functional theory (DFT)</pubmed_abstract><journal>Scientific reports</journal><pagination>4302</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11794853</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>CADD based designing and biological evaluation of novel triazole based thiazolidinedione coumarin hybrids as antidiabetic agent.</pubmed_title><pmcid>PMC11794853</pmcid><pubmed_authors>Bedi PMS</pubmed_authors><pubmed_authors>Rana R</pubmed_authors><pubmed_authors>Megha</pubmed_authors><pubmed_authors>Kumar N</pubmed_authors><pubmed_authors>Dhir M</pubmed_authors><pubmed_authors>Kaur S</pubmed_authors><pubmed_authors>Sharma A</pubmed_authors><pubmed_authors>Singh JV</pubmed_authors><pubmed_authors>Gulati HK</pubmed_authors><pubmed_authors>Narang A</pubmed_authors><pubmed_authors>Khanna A</pubmed_authors><pubmed_authors>Pooja</pubmed_authors><pubmed_authors>Jyoti</pubmed_authors></additional><is_claimable>false</is_claimable><name>CADD based designing and biological evaluation of novel triazole based thiazolidinedione coumarin hybrids as antidiabetic agent.</name><description>A series of 5-(substituted benzylidene) thiazolidine-2,4-dione and coumarin hybrids (I-1 to I-16) were designed and synthesized to explore key structural requirements for effective α-glucosidase inhibitors. Molecular docking studies were conducted to investigate their interactions with various targets, including DPP-4, α-glucosidase, α-amylase, and PPAR-γ. The docking scores and binding energies indicated that Compound I-1 emerged as the optimal scaffold for drug design, excluding α-amylase. Compound I-1 was synthesized based on the insights gained from molecular docking and simulations, which helped predict interactions and identify critical structural features. Pharmacokinetic properties were evaluated through drug-likeness and ADMET studies. Additionally, density functional theory (DFT)</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Feb</publication><modification>2026-06-02T16:11:46.348Z</modification><creation>2025-04-04T07:26:34.799Z</creation></dates><accession>S-EPMC11794853</accession><cross_references><pubmed>39905269</pubmed><doi>10.1038/s41598-025-88944-y</doi></cross_references></HashMap>